5 completed, 3 recruiting, 3 unknown, 2 terminated. 14 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 14 | Completed 5, Recruiting 3, Unknown 3, Terminated 2, Withdrawn 1 |
| Phase 2 | 6 | Completed 2, Unknown 2, Recruiting 1, Terminated 1 |
Follow Facial Neuralgia: new trials by email Literature Review of Facial Neuralgia trials Research Report on Facial Neuralgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia RP-008, Varenicline tartrate - Trigeminal Neuralgia | Phase 1 / Phase 2 | Recruiting | Kriya Therapeutics, Inc. | 24 | 2026-09-10 | 2026-10-23 |
| Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion Deep brain stimulation - Trigeminal Neuralgia | Phase 1 | Recruiting | Université de Sherbrooke | 6 | 2024-10-15 | 2024-12-12 |
| The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome intramuscular Botulinum Toxin - Myofacial Pain Syndrome | Phase 1 / Phase 2 | Completed | Yassir R. Al-khannaq | 14 | 2024-03-12 | 2025-02-13 |
| Risk of Nerve Damage After Administration of Local Anesthesia 4% Articaine with 1:200,000 epinephrine, 2% lidocaine with 1:100,000 epinephrine - Inferior Alveolar Nerve Injuries | Phase 1 | Unknown | Cleveland Dental Institute | 80 | 2024-01-01 | 2024-08-26 |
| Paresthesia-free Peripheral Nerve Field Stimulation for Trigeminal Neuralgia (FreeST Trial) Paresthesia-free Peripheral Nerve Field Stimulation, Sham stimulation - Trigeminal Neuralgia, Facial Pain | Phase 1 / Phase 2 | Unknown | University Health Network, Toronto | 24 | 2022-10-28 | 2024-02-23 |
| Safety of Cultured Allogeneic Adult Umbilical Cordor Placental Derived Stem Cells Exosomes for Trigeminal Neuralgia cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes - Peripheral Neuropathy, Trigeminal Neuralgia | Phase 1 | Recruiting | The Foundation for Orthopaedics and Regenerative Medicine | 20 | 2022-09-09 | 2026-10-20 |
| Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache Ketorolac, Dexamethasone - Chronic Migraine, Cluster Headache | Phase 1 | Withdrawn | Weill Medical College of Cornell University | 2020-10-01 | 2020-08-04 | |
| New Formulation and Food Effect Study of BIIB074 BIIB074 Treatment A, BIIB074 Treatment B, BIIB074 Treatment C - Trigeminal Neuralgia (TN), Other Neuropathic Pain | Phase 1 | Completed | Biogen | 28 | 2016-12-01 | 2017-02-27 |
| PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants BIIB074, Placebo - Healthy, Trigeminal Neuralgia | Phase 1 | Completed | Biogen | 64 | 2016-08-01 | 2017-03-09 |
| Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique Glycerol - Trigeminal Neuralgia, Headache Disorders | Phase 1 / Phase 2 | Terminated | Norwegian University of Science and Technology | 1 | 2016-05-01 | 2019-03-27 |
| Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. Botulinum Toxin Type A - Trigeminal Neuralgia, Headache Disorders | Phase 1 / Phase 2 | Completed | Norwegian University of Science and Technology | 10 | 2016-05-01 | 2019-07-29 |
| PK & Tolerability of CNV1014802 in Young and Elderly Healthy Volunteers CNV1014802, Placebo - Trigeminal Neuralgia | Phase 1 | Completed | Biogen | 32 | 2015-02-03 | 2017-10-12 |
| Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain. Epidural Motor Cortex Stimulation - Trigeminal Neuralgia (Burchiel Type I), Trigeminal Neuralgia (Burchiel Type II) | Phase 1 | Terminated | Johns Hopkins University | 1 | 2015-02-01 | 2019-02-18 |
| Clinical Trial of Hyperbaric Oxygen Treatment in Trigeminal Neuralgia Patients Hyperbaric oxygen, Mock hyperbaric chamber - Trigeminal Neuralgia, Pain | Phase 1 / Phase 2 | Unknown | Xijing Hospital | 30 | 2008-04-01 | 2009-03-20 |
Trigeminal Neuralgia (12) · Headache Disorders (2) · Cluster Headache (1) · Complex Regional Pain Syndromes (1) · Facial Pain (1) · Glossopharyngeal Nerve Diseases (1) · Mandibular Nerve Injuries (1) · Multiple Sclerosis (1) · Pain (1) · Peripheral Nervous System Diseases (1)
Cranial Nerve Diseases (14) · Facial Nerve Diseases (14) · Mouth Diseases (14) · Nervous System Diseases (14) · Stomatognathic Diseases (14) · Trigeminal Nerve Diseases (13) · Brain Diseases (3) · Central Nervous System Diseases (3) · Neurologic Manifestations (2) · Neuromuscular Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1)
vixotrigine (2) · Botulinum Toxins, Type A (1) · Carticaine (1) · Deep Brain Stimulation (1) · Dexamethasone (1) · Epinephrine (1) · Glycerol (1) · Ketorolac (1) · Lidocaine (1) · Varenicline (1)
Biogen (3) · Norwegian University of Science and Technology (2) · Cleveland Dental Institute (1) · Johns Hopkins University (1) · Kriya Therapeutics, Inc. (1) · The Foundation for Orthopaedics and Regenerative Medicine (1) · University Health Network, Toronto (1) · Université de Sherbrooke (1) · Weill Medical College of Cornell University (1) · Xijing Hospital (1) · Yassir R. Al-khannaq (1)
United States (5) · Canada (3) · Norway (2) · United Kingdom (2) · China (1) · Greece (1) · Iraq (1)
Erling A Tronvik, PhD, MD (2) · Ahmed A Hashem, PhD (1) · Athos Patsalides, MD, MPH (1) · Chadwick Prodromos, MD (1) · Frederick A Lenz, MD, PhD (1) · Mojgan Hodaie, MD, MSc (1) · Waleed Elmallah, PhD (1)
PMID 10916328, PMID 15793381, PMID 20006669, PMID 30734772, PMID 31342515, PMID 33384805, PMID 33990740, PMID 35162650
2014 (1), 2015 (1), 2016 (1)